Interventional: Page 30

Medtronic launches CareLink in Europe
By AuntMinnieEurope.com staff writers
Interventional technology firm Medtronic has received CE Mark approval for its CareLink Network with Conexus Wireless Telemetry, and the company plans to debut the device in the European Union.
August 29, 2007
Drug-eluting stents cut odds of revascularization in MI patients
By Reuters Health
NEW YORK (Reuters Health), May 25 - Use of drug-eluting stents rather than bare-metal ones reduces the likelihood of revascularization in MI patients without an increase in the risk of death or another MI, a meta-analysis of trial data suggests.
May 24, 2007
Reuterslogo
Arrow, Esaote ink distribution deal
By AuntMinnieEurope.com staff writers
Interventional accessories developer Arrow International of Reading, PA has signed a distribution agreement with ultrasound firm Esaote of Genoa, Italy.
April 18, 2007
Cordis, ClearStream team up
By AuntMinnieEurope.com staff writers
Interventional firm Cordis has signed a distribution agreement with Irish interventional technologies developer ClearStream Technologies Group.
April 17, 2007
Cordis debuts PTCA dilatation catheter
By AuntMinnieEurope.com staff writers
Johnson & Johnson subsidiary Cordis Endovascular has introduced its Dura Star Rx percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter in Europe.
April 9, 2007
Reconstruction kernel dramatically affects stent evaluation
By Eric Barnes
VIENNA - If the results of a phantom study are valid in patients, the choice of reconstruction kernel with 64-slice CT has a critical impact on coronary artery stent evaluations. And as Dr. Florian Wolf explained at today's cardiac imaging sessions at the European Congress of Radiology (ECR), the evaluation of stents for detecting restenosis is critical for patient outcomes.
March 10, 2007
2007 03 11 09 56 31 706
ACS revascularization practices not based on patient risk characteristics
By Reuters Health
NEW YORK (Reuters Health), Feb 20 - Data in a multinational registry indicate that, contrary to published guidelines, low-risk patients with acute coronary syndromes (ACS) are more likely to receive percutaneous coronary interventions than those at high risk.
February 19, 2007
Reuterslogo
FlowCardia launches Crosser stent portfolio in Europe
By AuntMinnieEurope.com staff writers
Endovascular device developer FlowCardia said that it is making its Crosser 14P, 14S, and 18 chronic total occlusion (CTO) recanalization catheters available in the European Union (EU).
January 24, 2007
Conor wins British patent victory
By AuntMinnieEurope.com staff writers
Conor Medsystems reported that the Court of Appeal in the U.K. unanimously upheld the decision of the High Court of Justice to revoke the U.K. portion of European Patent 0 706 376 B1 to Angiotech Pharmaceuticals.
January 15, 2007
Boston Scientific launches Promus
By AuntMinnieEurope.com staff writers
Interventional device developer Boston Scientific said that it has initiated international marketing of its Promus everolimus-eluting stent.
January 10, 2007
Cordis launches lower-leg catheters
By AuntMinnieEurope.com staff writers
Johnson & Johnson subsidiary Cordis Endovascular has introduced its Frontrunner XP chronic total occlusion (CTO) catheter and Outback re-entry catheter for the treatment of blocked lower-leg arteries in Europe, the Middle East, and Africa.
December 11, 2006
Abbott launches Xience V stent
By AuntMinnieEurope.com staff writers
Interventional device developer Abbott Vascular has begun the international launch of its Xience V everolimus-eluting coronary stent system, according to the Redwood City, CA-based company.
October 2, 2006
Previous Page
Page 30 of 32
Next Page